Redmile Group, LLC: holdings and changes

Number 23 of the top 100 funds by copy return. Redmile Group, LLC reported 44 US stocks worth $1.4B for the quarter ending 2026-09-30 and changed 6 new, 6 added, 22 trimmed and 1 sold since 2026-06-30.

Copy return, 4 quarters+60.1%
US 500, same time+14.5%
Size$1.4B
Stocks44

Holdings

StockChangeWeightValueShares
NRIX
Nurix Therapeutics INC
ADD +94%13.71%$187M7,901,085
KRYS
Krystal Biotech INC
TRIM -17%12.84%$176M527,684
SRRK
Scholar Rock Hldg Corp
TRIM -30%10.73%$147M3,033,962
STOK
Stoke Therapeutics INC
7.36%$101M3,869,028
IMNM
Immunome INC
TRIM -11%6.87%$94M4,363,064
ABSI
Absci Corporation
5.26%$72M6,671,377
ETRA
Electra Therapeutics INC
BUY4.47%$61M5,430,918
ANNX
Annexon INC
ADD +20%4.42%$60M14,278,075
NGNE
Neurogene INC Com
ADD +11%3.18%$44M1,562,199
RGNX
Regenxbio INC
ADD +16%2.78%$38M5,048,502
STTK
Shattuck Labs INC
TRIM -26%2.54%$35M5,086,990
FATE
Fate Therapeutics INC
2.23%$30M12,872,946
SLN
Silence Therapeutics PLC
ADD +14%1.97%$27M2,460,894
BEAM
Beam Therapeutics INC
TRIM -9%1.90%$26M1,061,782
ATTO
Attovia Therapeutics INC
BUY1.46%$20M1,163,587
AGMB
Agomab Therapeutics Nv
TRIM -36%1.41%$19M1,740,230
NUVB
Nuvation Bio INC
1.24%$17M3,031,009
ADRX
Adarx Pharmaceuticals INC
BUY1.12%$15M769,345
IDYA
Ideaya Biosciences INC
TRIM -40%1.07%$15M381,319
ADCT
Adc Therapeutics Sa
1.03%$14M11,584,552
SLDB
Solid Biosciences INC
1.03%$14M1,944,342
ZYME
Zymeworks INC
0.95%$13M491,654
OBX
Obsidian Therapeutics INC
BUY0.84%$11M833,157
BMRN
Biomarin Pharmaceutical INC
TRIM -29%0.83%$11M189,538
ELIEM THERAPEU
Eliem Therapeutics INC
TRIM -21%0.82%$11M974,489
CLDX
Celldex Therapeutics INC
TRIM -26%0.76%$10M321,770
ALXO
Alx Oncology Holdings INC
0.73%$10M7,185,263
AURA
Aura Biosciences INC
TRIM -7%0.71%$10M1,552,479
COGT
Cogent Biosciences INC
TRIM -41%0.70%$10M296,606
CBLL
Ceribell INC
0.69%$9M386,786
ODTX
Odyssey Therapeutics, INC.
TRIM -12%0.61%$8M374,510
XENE
Xenon Pharmaceuticals INC
TRIM -17%0.52%$7M191,036
Livanova Plc O
Livanova PLC Ord
TRIM -10%0.47%$6M84,132
ATRA
Atara Biotherapeutics INC
ADD +44%0.40%$5M636,852
INSM
Insmed INC.
TRIM -16%0.36%$5M42,902
EPRX
Eupraxia Pharmaceuticals INC
TRIM -15%0.35%$5M519,881
DBVT
Dbv Technologies S A
TRIM -9%0.32%$4M373,417
ORIC
Oric Pharmaceuticals INC
TRIM -19%0.29%$4M292,817
TCGX
Tcgx Acquisition Corp
BUY0.27%$4M299,860
PRME
Prime Medicine INC
TRIM -17%0.26%$4M1,146,860
ADAGIO THERAPE
Adagio Therapeutics INC
TRIM -12%0.15%$2M2,285,320
OCUL
Ocular Therapeutix INC
BUY0.14%$2M243,954
ARDX
Ardelyx INC
TRIM -18%0.13%$2M523,870
PLRX
Pliant Therapeutics INC
0.06%$800k772,126
ESTA
Establishment Labs Hldgs INC
SELL0%was $8M0

Copy return each quarter

HeldFund copyUS 500
2023-06-30 → 2023-09-30-11.0%-3.6%
2023-09-30 → 2023-12-31+27.5%+11.2%
2023-12-31 → 2024-03-31+10.5%+10.0%
2024-06-30 → 2024-09-30+10.6%+5.4%
2024-09-30 → 2024-12-31-17.6%+2.1%
2024-12-31 → 2025-03-31-21.7%-4.6%
2025-03-31 → 2025-06-30+11.3%+10.5%
2025-06-30 → 2025-09-30+21.8%+7.8%
2025-09-30 → 2025-12-31+40.7%+2.4%
2025-12-31 → 2026-03-31+0.8%-4.6%
2026-03-31 → 2026-06-30+26.9%+14.8%
2026-06-30 → 2026-09-30-11.0%+2.1%

The copy return buys the fund's reported stocks on the day after the filing became public and holds them for one quarter, so it measures what anyone reading the filings could have done.

All top 100 funds, live

Other top funds

Nextech Invest LTD.Venrock Adviser, LLCFairmount Funds Management LLCTalos Eurisko Asset Management LPAnalog Century Management LPQvt Financial LPBroad Peak Investment Advisers Pte LTDWs Management LllpBvf INC/IlParadigm Biocapital Advisors LPOak Grove Capital LLCCm Wealth Advisors LLCAvidity Partners Management LPFirst Light Asset Management, LLCLogos Global Management LPSummit Street Capital Management, LLCMadison Avenue Partners, LPDivisar Capital Management LLCTcg Crossover Management, LLCOptimus Prime Fund Management Co., LTD.Value Aligned Research Advisors, LLCBraidwell LPOrbimed Advisors LLCMpm Bioimpact LLCCloudalpha Capital Management Limited/Hong KongGeneral Pension Society Pzu Joint Stock CoAmanah Holdings TrustSlate Path Capital LPDeep Track Capital, LP